We are currently experiencing technical issues due to the Microsoft outage. This will affect delivery of multi-factor authentication emails, invoice emails and service emails. We apologise for the disruption.

Explore 3 Stock Ideas & Industry Insights Download Free Report

News

This Nasdaq Aerospace Stock Is Down 5% Pre-Market Despite a Blowout Quarter

Elmet Group (NASDAQ:ELMT), a Portland, Maine based manufacturer of precision-engineered components and advanced high-energy systems serving the aerospace, defense, and government markets, is trading lower in pre-market activity, giving back a portion of Monday's post-earnings gains. The pullback comes despite blowout second-quarter results reported …

Nitish Kishor | 18 August 2026

Lam Research (NASDAQ:LRCX) Shares Fall 5% Pre-Market Amid Tech Sell-Off

Lam Research (NASDAQ:LRCX), a leading global supplier of wafer fabrication equipment and services to the semiconductor industry, is trading sharply lower in pre-market activity, giving back gains from a recent run to multi-year highs. The pullback comes amid a broader technology and semiconductor sell-off …

Nitish Kishor | 18 August 2026

Why Is Lumentum (NASDAQ:LITE) Stock Falling Pre-Market Despite Earnings Beat?

Lumentum Holdings (NASDAQ:LITE), a leading global manufacturer of optical and photonic products spun off from JDS Uniphase in 2015, is trading lower in pre-market activity, giving back a portion of an explosive rally that followed blowout fiscal fourth-quarter results. Revenue surged 109 percent year …

Nitish Kishor | 18 August 2026

Why Is POET Technologies (NASDAQ:POET) Stock Falling Pre-Market Today?

POET Technologies (NASDAQ:POET), a Toronto headquartered design and development company specializing in photonic integrated packaging solutions built around its proprietary optical interposer platform, is trading lower in pre-market activity, extending Monday's decline. The pullback follows a dramatic run-up earlier this year tied to speculation …

Nitish Kishor | 18 August 2026

This Nasdaq Biotech Penny Stock Is Cooling Off After an 18% Rally

Acurx Pharmaceuticals (NASDAQ:ACXP) shares are trading lower in pre-market activity, consolidating after a sharp gain in the prior session. Acurx is a Staten Island, New York-based late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, including Clostridioides difficile, MRSA, vancomycin-resistant …

Nitish Kishor | 18 August 2026

Why Is This Nasdaq Biotechnology Stock Up 21% Ahead of a Major Trial Readout?

Amylyx Pharmaceuticals (NASDAQ:AMLX) shares are surging in pre-market trading as investors position ahead of a major clinical trial announcement. Amylyx is a Cambridge, Massachusetts-based clinical-stage biopharmaceutical company founded in 2013, focused on developing novel therapies for diseases with high unmet need across neurodegenerative and …

Nitish Kishor | 18 August 2026

This Nasdaq Biotech Penny Stock Just Won a Key Patent. So Why Is It Falling?

Artelo Biosciences (NASDAQ:ARTL) shares are trading lower in pre-market activity, extending a decline from Thursday's session, even though the company announced a meaningful intellectual property milestone. Artelo is a Solana Beach, California-based clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for …

Nitish Kishor | 18 August 2026

Coherus Oncology (NASDAQ:CHRS) Penny Stock Rises on Special Dividend Announcement

Coherus Oncology (NASDAQ:CHRS) shares are trading higher in pre-market activity after the company announced a special dividend tied to the planned divestiture of its remaining biosimilar business. Coherus is a Redwood City, California-based, fully integrated commercial-stage oncology company with an approved next-generation PD-1 inhibitor, …

Nitish Kishor | 18 August 2026

This Nasdaq Healthcare Penny Stock Is Down 15% Despite a New Acquisition. Why?

DocGo (NASDAQ:DCGO) shares are trading sharply lower in pre-market activity after the company's second-quarter results overshadowed a newly announced acquisition. DocGo is a New York City-based, technology-enabled provider of mobile health services and medical transportation, delivering care through a proprietary digital platform offering mobile …

Nitish Kishor | 18 August 2026

This NYSE Medical Device Stock Is Up 7% Pre-Market. Here's Why.

Haemonetics (NYSE:HAE) shares are surging in pre-market trading, extending a strong run that followed the company's most recent quarterly report. Haemonetics is a global medical technology company headquartered in Boston, Massachusetts, dedicated to improving the quality, effectiveness, and efficiency of healthcare through innovative medical …

Nitish Kishor | 18 August 2026
Support

Hi! How can we help you today?

Loading…